SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRtw Biotech Regulatory News (RTW)

Share Price Information for Rtw Biotech (RTW)

Share Price is delayed by 15 minutes
Get Live Data
2.21    0.00 (0.00%)
Bid:
2.19
Ask:
2.21
Spread: 0.02 (0.913%)
Market Cap: $714.60m
RTW Live PriceLast checked at - London Stock Exchange

Intraday Rtw Biotech Share Chart

Total Voting Rights

1 May 2026 07:00

RNS Number : 6743C
RTW Biotech Opportunities Ltd
01 May 2026
 

LEI: 549300Q7EXQQH6KF7Z84

1 May 2026

RTW Biotech Opportunities Ltd (the "Company")

Total Voting Rights

In accordance with DTR 5.6.1 of the FCA's Disclosure Guidance and Transparency Rules, the Company notifies the following:

 

As at the close of business on 30 April 2026, the Company had 345,967,440 Ordinary Shares in issue, of which 22,320,003 were held in treasury. Therefore, the total number of voting rights in the Company at that date was 323,647,437.

 

The above figure of 323,647,437 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

Enquiries:

RTW Investments, LP - Investment Manager

Oliver Kenyon (Business & Corporate Development)

Krisha McCune (Investor Relations)

 

+44 (0)20 7959 6362

biotechopportunities@rtwfunds.com

Altum (Guernsey) Limited

Joanna Duquemin Nicolle

Sadie Morrison

 

+44 (0)1481 703 100

 

About RTW Biotech Opportunities Ltd:

RTW Biotech Opportunities Ltd (LSE: RTW) is an investment fund focused on identifying transformative assets with high growth potential across the biopharmaceutical and medical technology sectors. Driven by a long-term approach to support innovative businesses, RTW Biotech Opportunities Ltd invests in companies developing next-generation therapies and technologies that can significantly improve patients' lives. RTW Biotech Opportunities Ltd is managed by RTW Investments, LP, a leading healthcare-focused entrepreneurial investment firm with deep scientific expertise and a strong track record of supporting companies developing life-changing therapies.

Visit the website at www.rtwbio.com for more information.

 

***********

The information in this announcement may include forward-looking statements, which are based on the current expectations and projections about future events, and in certain cases can be identified by the use of terms such as "may", "will", "should", "expect", "anticipate", "project", "estimate", "intend", "continue", "target", "believe" (or the negatives thereon) or other variations thereon or comparable terminology. These forward-looking statements are subject to risks, uncertainties and assumptions, and therefore the events in the forward-looking statements may not occur.

***********

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVRQBLFXQZLBBBV
Date   Source Headline
19th Aug 20217:05 amRNSDirector/PDMR Shareholding
19th Aug 20217:05 amRNSDirector/PDMR Shareholding
19th Aug 20217:00 amRNSNotice of Interim Report
17th Aug 20217:00 amRNSIssue of Equity
13th Aug 20214:05 pmRNSAnnouncement of Share Issuance
13th Aug 20217:00 amRNSNet Asset Value(s)
6th Aug 20217:00 amRNSCompletion of Transfer
5th Aug 20211:00 pmRNSTransfer to the Premium Segment of the LSE
2nd Aug 20217:01 amRNSPortfolio Company Update: Tenaya Therapeutics IPO
2nd Aug 20217:00 amRNSQuarterly Update
30th Jul 20213:50 pmRNSResult of Meeting
27th Jul 20217:05 amRNSNew Investment in Artios
15th Jul 20217:00 amRNSNet Asset Value(s)
14th Jul 20217:05 amRNSPortfolio Company Update
14th Jul 20217:00 amRNSPublication of Circular
1st Jul 20217:00 amRNSTotal Voting Rights
28th Jun 20217:00 amRNSPortfolio Company Update: GH Research IPO
25th Jun 20217:00 amRNSPortfolio Company Update: Monte Rosa IPO
22nd Jun 20214:49 pmRNSResult of AGM
18th Jun 20214:40 pmRNSSecond Price Monitoring Extn
18th Jun 20214:35 pmRNSPrice Monitoring Extension
16th Jun 20217:00 amRNSIssue of Equity
15th Jun 202112:05 pmRNSNew Investment in Umoja Biopharma
14th Jun 20212:32 pmRNSAnnouncement of Share Issuance
14th Jun 20217:00 amRNSNet Asset Value(s)
9th Jun 202112:05 pmRNSNew Investment in Alcyone Therapeutics
2nd Jun 20217:00 amRNSNotice of AGM
26th May 20211:05 pmRNSAdditional Investment in Portfolio Company
20th May 20218:05 amRNSNew Investment in Numab Therapeutics
14th May 20217:00 amRNSNet Asset Value(s)
29th Apr 20217:00 amRNSAnnual Financial Report
28th Apr 20217:00 amRNSQuarterly Update
19th Apr 20217:00 amRNSPortfolio Company Update: Biomea IPO
15th Apr 20217:00 amRNSNet Asset Value(s)
1st Apr 20217:05 amRNSTotal Voting Rights
1st Apr 20217:00 amRNSNotice of Annual Report
30th Mar 20211:00 pmRNSNew Investment in Pyxis Oncology
17th Mar 20217:00 amRNSIssue of Equity
15th Mar 20217:01 amRNSAnnouncement of Share Issuance
15th Mar 20217:00 amRNSPortfolio Company Update: Prometheus IPO
12th Mar 202112:30 pmRNSNew Investment in Monte Rosa Therapeutics
12th Mar 20217:00 amRNSNet Asset Value(s)
9th Mar 20211:45 pmRNSNew Investment in Ventyx Biosciences
9th Mar 202112:45 pmRNSNew Investment in Visus Therapeutics
1st Mar 20211:00 pmRNSNew Investment in Tenaya Therapeutics
1st Mar 20217:00 amRNSTotal Voting Rights
26th Feb 20211:15 pmRNSNew Investment in Artiva Biotherapeutics
18th Feb 20217:00 amRNSIssue of Equity
15th Feb 20214:10 pmRNSAnnouncement of Share Issuance
15th Feb 20217:00 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.